Onconetix Inc.(ONCO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ONCO Onconetix Inc.

盘前交易 12-24 09:14:37 EST

1.58

-0.02

-1.56%

盘前1.58

+0.000.00%

08:31 EST

最高1.60	最低1.56	成交量2.15万
今开1.60	昨收1.61	日振幅2.49%
总市值246.59万	流通市值196.43万	总股本156.07万
成交额3.42万	换手率1.73%	流通股本124.32万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ONCO","market":"US","secType":"STK","nameCN":"Onconetix Inc.","latestPrice":1.58,"timestamp":1766523600000,"preClose":1.605,"halted":0,"volume":21511,"hourTrading":{"tag":"盘前","latestPrice":1.58,"preClose":1.58,"latestTime":"08:31 EST","volume":563,"amount":884.0300316,"timestamp":1766583113869},"delay":0,"floatShares":1243200,"shares":1560668,"eps":-89.08425,"marketStatus":"盘前交易","change":-0.025,"latestTime":"12-24 09:14:37 EST","open":1.6,"high":1.6,"low":1.56,"amount":34173.678167,"amplitude":0.024922,"askPrice":2.02,"askSize":300,"bidPrice":1.14,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-89.08425,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766586600000},"marketStatusCode":1,"adr":0,"listingDate":1645160400000,"exchange":"NASDAQ","adjPreClose":1.58,"preHourTrading":{"tag":"盘前","latestPrice":1.58,"preClose":1.58,"latestTime":"08:31 EST","volume":563,"amount":884.0300316,"timestamp":1766583113869},"postHourTrading":{"tag":"盘后","latestPrice":1.57,"preClose":1.58,"latestTime":"16:10 EST","volume":1503,"amount":2369.74,"timestamp":1766524204928},"volumeRatio":0.30848593352221665},"requestUrl":"/m/hq/s/ONCO","defaultTab":"news","newsList":[{"id":"1172459660","title":"Onconetix Inc. - 提交22.1百万普通股转售的招股说明书 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1172459660","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172459660?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:36","pubTimestamp":1763570197,"startTime":"0","endTime":"0","summary":"11月5日 - Onconetix Inc. ::*ONCONETIX INC - 提交22.1百万普通股转售的招股说明书，卖方股东 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2580417790","title":"Onconetix, Inc.盘中异动 股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580417790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580417790?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:50","pubTimestamp":1761918624,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日21时50分，Onconetix, Inc.股票出现异动，股价大幅下挫5.80%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Ardelyx, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Travere Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Intensity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为915.51%、220.19%、134.78%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Intensity Therapeutics, Inc.，振幅分别为24.63%、21.96%、20.64%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103121502494e796a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103121502494e796a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"1147603757","title":"Onconetix Inc. - 招股说明书涉及销售股东最多5,100,000股普通股的提供和销售 - 文件备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1147603757","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147603757?lang=zh_cn&edition=full","pubTime":"2025-10-16 18:09","pubTimestamp":1760609347,"startTime":"0","endTime":"0","summary":"Onconetix Inc. - 招股说明书涉及销售股东最多5,100,000股普通股的提供和销售 - 文件备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2572581647","title":"Onconetix, Inc.盘中异动 快速跳水5.61%报3.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572581647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572581647?lang=zh_cn&edition=full","pubTime":"2025-09-30 23:56","pubTimestamp":1759247769,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日23时56分，Onconetix, Inc.股票出现波动，股价快速跳水5.61%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Scisparc Ltd.、Zura Bio Limited涨幅较大，Scisparc Ltd.、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2059.74%、316.11%、281.99%，振幅较大的相关个股有Zura Bio Limited、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为50.84%、44.81%、35.39%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930235609a44ee002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930235609a44ee002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"1140205978","title":"Onconetix Inc.宣布通过1290万美元D轮优先股和认股权证私募配售完成融资，终止与Ocuvex Inc.的并购协议并与Veru Inc.达成880万美元债务和解","url":"https://stock-news.laohu8.com/highlight/detail?id=1140205978","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140205978?lang=zh_cn&edition=full","pubTime":"2025-09-26 20:33","pubTimestamp":1758889989,"startTime":"0","endTime":"0","summary":"Onconetix Inc.宣布通过1290万美元D轮优先股和认股权证私募配售完成融资，同时终止与Ocuvex Inc.的并购协议，并与Veru Inc.达成880万美元债务和解。\n此次融资将为公司提供重要的资金支持，而终止与Ocuvex Inc.的合并协议以及与Veru Inc.达成的债务和解协议，将有助于公司重新调整战略方向，专注于核心业务发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"1160349549","title":"Onconetix Inc与Ocuvex决定各自独立发展最符合利益相关者利益","url":"https://stock-news.laohu8.com/highlight/detail?id=1160349549","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160349549?lang=zh_cn&edition=full","pubTime":"2025-09-26 20:17","pubTimestamp":1758889038,"startTime":"0","endTime":"0","summary":"Onconetix Inc与Ocuvex经过评估后认为，双方各自独立发展的路径最符合利益相关者的最佳利益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"1137053033","title":"Onconetix Inc.宣布子公司Proteomedix向Immunovia授权制造知识产权，助力后者独立生产胰腺癌检测试剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1137053033","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137053033?lang=zh_cn&edition=full","pubTime":"2025-09-22 20:01","pubTimestamp":1758542487,"startTime":"0","endTime":"0","summary":"Onconetix Inc.日前宣布，其子公司Proteomedix已向Immunovia授权相关制造知识产权，此举将使Immunovia能够独立生产其胰腺癌检测产品PancreasureTM所需的关键试剂。\n通过这项授权协议，Immunovia将获得必要的技术支持，提升其在胰腺癌早期检测领域的自主生产能力，进一步巩固其在精准医疗诊断市场的地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2558131256","title":"Onconetix, Inc.8月11日成交额为26.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558131256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558131256?lang=zh_cn&edition=full","pubTime":"2025-08-12 12:58","pubTimestamp":1754974712,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Onconetix, Inc.成交额为26.46万美元，成交额较昨日减少84.20%，当日成交量为9.51万股。Onconetix, Inc.于2025年8月11日涨0.0%，报2.84美元，该股过去5个交易日跌10.41%，年初至今跌94.7%，过去60日跌64.07%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|26.46万|-84.20%|9.51万|#|2025-08-08|167.47万|317.44%|60.49万|#|2025-08-07|40.12万|-31.27%|14.68万|#|2025-08-06|58.37万|37.92%|19.87万|#|2025-08-05|42.32万|-52.76%|13.76万|Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812125839a48349e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812125839a48349e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2558506595","title":"Onconetix, Inc.8月8日成交额为167.47万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558506595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558506595?lang=zh_cn&edition=full","pubTime":"2025-08-09 12:58","pubTimestamp":1754715488,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Onconetix, Inc.成交额为167.47万美元，成交额较昨日增加317.44%，当日成交量为60.49万股。Onconetix, Inc.于2025年8月8日涨6.37%，报2.84美元，该股过去5个交易日跌17.68%，年初至今跌94.7%，过去60日跌56.04%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-08|167.47万|317.44%|60.49万|#|2025-08-07|40.12万|-31.27%|14.68万|#|2025-08-06|58.37万|37.92%|19.87万|#|2025-08-05|42.32万|-52.76%|13.76万|#|2025-08-04|89.58万|-30.12%|27.39万|Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809125813a47e5b11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809125813a47e5b11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2557289512","title":"Onconetix, Inc.8月7日成交额为40.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557289512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557289512?lang=zh_cn&edition=full","pubTime":"2025-08-08 12:55","pubTimestamp":1754628930,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Onconetix, Inc.成交额为40.12万美元，成交额较昨日减少31.27%，当日成交量为14.68万股。Onconetix, Inc.于2025年8月7日跌9.18%，报2.67美元，该股过去5个交易日跌25.0%，年初至今跌95.01%，过去60日跌55.13%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-07|40.12万|-31.27%|14.68万|#|2025-08-06|58.37万|37.92%|19.87万|#|2025-08-05|42.32万|-52.76%|13.76万|#|2025-08-04|89.58万|-30.12%|27.39万|#|2025-08-01|128.19万|-98.81%|38.75万|Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808125538a47c65b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808125538a47c65b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2557301873","title":"Onconetix, Inc.盘中异动 下午盘急速跳水5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557301873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557301873?lang=zh_cn&edition=full","pubTime":"2025-08-07 02:06","pubTimestamp":1754503603,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日02时06分，Onconetix, Inc.股票出现波动，股价急速下跌5.28%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Biomx Inc.、Rigel Pharmaceuticals, Inc.、Avidity Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为719.86%、571.92%、100.04%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为57.18%、48.52%、47.87%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807020644a4793115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807020644a4793115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2557392157","title":"Onconetix, Inc.盘中异动 急速下跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557392157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557392157?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:32","pubTimestamp":1754400747,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日21时32分，Onconetix, Inc.股票出现异动，股价快速下挫5.36%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为3.08%。其相关个股中，Y-Mabs Therapeutics, Inc.、Shattuck Labs, Inc.、Adaptimmune Therapeutics Plc涨幅较大，Shattuck Labs, Inc.、Adaptimmune Therapeutics Plc、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为101.24%、75.09%、62.13%，振幅较大的相关个股有Plus Therapeutics, Inc.、Cellectis Ads Each Repr 1 Ord Spon、Shattuck Labs, Inc.，振幅分别为12.18%、10.60%、10.37%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213227a476b6bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213227a476b6bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STTK","BK4139","ONCO"],"gpt_icon":0},{"id":"2556382288","title":"Onconetix, Inc.盘中异动 股价大跌5.51%报3.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556382288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556382288?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:31","pubTimestamp":1754314273,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时31分，Onconetix, Inc.股票出现异动，股价急速下跌5.51%。截至发稿，该股报3.26美元/股，成交量1.6504万股，换手率3.16%，振幅0.29%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213113a6d2828f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213113a6d2828f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2556847712","title":"Onconetix, Inc.8月1日成交额为128.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556847712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556847712?lang=zh_cn&edition=full","pubTime":"2025-08-02 12:50","pubTimestamp":1754110258,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日，Onconetix, Inc.成交额为128.19万美元，成交额较昨日减少98.81%，当日成交量为38.75万股。Onconetix, Inc.于2025年8月1日跌3.09%，报3.45美元，该股过去5个交易日跌16.87%，年初至今跌93.56%，过去60日跌41.18%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-01|128.19万|-98.81%|38.75万|#|2025-07-31|1.08亿|13357.43%|2607.01万|#|2025-07-30|80.11万|55.45%|24.61万|#|2025-07-29|51.53万|-65.35%|13.86万|#|2025-07-28|148.70万|-68.25%|39.57万|Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802125059a6ceda9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802125059a6ceda9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2556869217","title":"Onconetix, Inc.7月31日成交额为1.08亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556869217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556869217?lang=zh_cn&edition=full","pubTime":"2025-08-01 12:48","pubTimestamp":1754023721,"startTime":"0","endTime":"0","summary":"美东时间2025年7月31日，Onconetix, Inc.成交额为1.08亿美元，成交额较昨日增加13357.43%，当日成交量为2607.01万股。Onconetix, Inc.于2025年7月31日涨10.9%，报3.56美元，该股过去5个交易日跌1.39%，年初至今跌93.35%，过去60日跌40.17%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-31|1.08亿|13357.43%|2607.01万|#|2025-07-30|80.11万|55.45%|24.61万|#|2025-07-29|51.53万|-65.35%|13.86万|#|2025-07-28|148.70万|-68.25%|39.57万|#|2025-07-25|468.34万|1221.95%|116.97万|Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801124843a6ccfdd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801124843a6ccfdd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2555102893","title":"Onconetix, Inc.盘中异动 急速跳水5.80%报3.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555102893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555102893?lang=zh_cn&edition=full","pubTime":"2025-07-30 22:55","pubTimestamp":1753887346,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日22时55分，Onconetix, Inc.股票出现波动，股价快速下跌5.80%。截至发稿，该股报3.41美元/股，成交量4.0608万股，换手率7.78%，振幅6.07%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730225546a46bd108&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730225546a46bd108&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2554724137","title":"Onconetix, Inc.盘中异动 早盘急速跳水7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554724137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554724137?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:31","pubTimestamp":1753709506,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时31分，Onconetix, Inc.股票出现波动，股价大幅跳水7.17%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Cervomed Inc.涨幅较大，Aim Immunotech Inc.、Cervomed Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为222.64%、81.27%、80.75%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Lexaria Bioscience Corp.，振幅分别为35.83%、23.86%、10.21%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213146a6c6155f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213146a6c6155f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2551126575","title":"Onconetix, Inc.盘中异动 股价大跌16.25%报3.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551126575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551126575?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:31","pubTimestamp":1752672706,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时31分，Onconetix, Inc.股票出现波动，股价急速下挫16.25%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Qualigen Therapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Briacell Therapeutics Corp C/Wts 26/02/2026涨幅较大，Qualigen Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为1483.08%、880.77%、369.55%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、知临集团、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为26.06%、13.40%、10.78%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213147a6ada0c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213147a6ada0c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2551848441","title":"Onconetix, Inc.盘中异动 早盘股价大涨5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551848441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551848441?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:33","pubTimestamp":1752500009,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时33分，Onconetix, Inc.股票出现异动，股价快速上涨5.91%。Onconetix, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Dare Bioscience, Inc.、Biomx Inc.、Rani Therapeutics Holdings, Inc.涨幅较大，Windtree Therapeutics, Inc.、Dare Bioscience, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1619.76%、335.48%、170.85%，振幅较大的相关个股有Dare Bioscience, Inc.、Biomx Inc.、Rani Therapeutics Holdings, Inc.，振幅分别为45.33%、44.41%、17.95%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213329a6a8f0ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213329a6a8f0ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2550653457","title":"Onconetix, Inc.盘中异动 股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550653457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550653457?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:52","pubTimestamp":1752069162,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时52分，Onconetix, Inc.股票出现异动，股价快速上涨5.42%。Onconetix, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，Calidi Biotherapeutics, Inc.、Prokidney Corp.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为677.69%、578.41%、450.29%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Calidi Biotherapeutics, Inc.、Prokidney Corp.，振幅分别为79.09%、56.72%、39.41%。Onconetix, Inc.公司简介：Onconetix Inc 是一家处于商业化阶段的生物技术公司，专注于男性健康和肿瘤学领域的研究、开发和商业化解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709215242979fbad0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709215242979fbad0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONCO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onconetix.com","stockEarnings":[{"period":"1week","weight":-0.1835},{"period":"1month","weight":-0.2851},{"period":"3month","weight":-0.5016},{"period":"6month","weight":-0.6602},{"period":"1year","weight":-0.9467},{"period":"ytd","weight":-0.9705}],"compareEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":0.0439},{"period":"3month","weight":0.0406},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.1568},{"period":"ytd","weight":0.1738}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Onconetix, Inc.于2018年10月26日在特拉华州注册成立。该公司是一家商业阶段的生物技术公司，专注于为临床医生和患者提供肿瘤学专有疗法、诊断和服务的研究、开发和商业化。该公司目前拥有FDA批准的用于治疗良性前列腺增生（BPH）（一种前列腺疾病）的口服治疗药物EntadFi，以及用于在前列腺癌肿瘤学中筛查和诊断前列腺特异性抗原（PSA）评估不确定的男性的先进专有诊断系统Proclarix。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.017619},{"month":2,"riseRate":0,"avgChangeRate":-0.233116},{"month":3,"riseRate":0.25,"avgChangeRate":-0.182623},{"month":4,"riseRate":0,"avgChangeRate":-0.309723},{"month":5,"riseRate":0.75,"avgChangeRate":0.202403},{"month":6,"riseRate":0.25,"avgChangeRate":-0.145881},{"month":7,"riseRate":0.25,"avgChangeRate":0.061534},{"month":8,"riseRate":0,"avgChangeRate":-0.163365},{"month":9,"riseRate":0.25,"avgChangeRate":-0.19953},{"month":10,"riseRate":0.25,"avgChangeRate":-0.216685},{"month":11,"riseRate":0.25,"avgChangeRate":-0.325466},{"month":12,"riseRate":0,"avgChangeRate":-0.206782}],"exchange":"NASDAQ","name":"Onconetix Inc.","nameEN":"Onconetix Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Onconetix Inc.(ONCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Onconetix Inc.(ONCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Onconetix Inc.,ONCO,Onconetix Inc.股票,Onconetix Inc.股票老虎,Onconetix Inc.股票老虎国际,Onconetix Inc.行情,Onconetix Inc.股票行情,Onconetix Inc.股价,Onconetix Inc.股市,Onconetix Inc.股票价格,Onconetix Inc.股票交易,Onconetix Inc.股票购买,Onconetix Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Onconetix Inc.(ONCO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Onconetix Inc.(ONCO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}